China Resources Medical Holdings Company Limited (1PH) — Working Capital to Net Assets Ratio
China Resources Medical Holdings Company Limited (1PH) has a Working Capital to Net Assets ratio of -15.6% as of June 2025. Working capital of €-1.21 Billion (current assets of €3.51 Billion minus current liabilities of €4.72 Billion) is measured against net assets of €7.77 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 1PH equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
China Resources Medical Holdings Company Limited Working Capital to Net Assets (2016–2024)
This chart shows how China Resources Medical Holdings Company Limited's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at -15.6%, reflecting working capital of €-1.21 Billion against net assets of €7.77 Billion EUR. Check China Resources Medical Holdings Company tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for China Resources Medical Holdings Company Limited (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for China Resources Medical Holdings Company Limited from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see China Resources Medical Holdings Company stock valuation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -16.8% | €-1.26 Billion | €7.50 Billion | €3.24 Billion | €4.50 Billion | ▲ +8.5 pp |
| 2023 | -25.4% | €-1.78 Billion | €7.01 Billion | €3.43 Billion | €5.21 Billion | ▼ -50.8 pp |
| 2022 | 25.5% | €1.78 Billion | €7.00 Billion | €4.67 Billion | €2.89 Billion | ▲ +18.5 pp |
| 2021 | 7.0% | €480.85 Million | €6.85 Billion | €3.92 Billion | €3.44 Billion | ▼ -23.6 pp |
| 2020 | 30.6% | €1.94 Billion | €6.34 Billion | €4.15 Billion | €2.21 Billion | ▲ +1.1 pp |
| 2019 | 29.5% | €1.81 Billion | €6.14 Billion | €3.20 Billion | €1.38 Billion | ▲ +7.5 pp |
| 2018 | 22.0% | €1.26 Billion | €5.71 Billion | €2.53 Billion | €1.28 Billion | ▲ +1.7 pp |
| 2017 | 20.3% | €1.14 Billion | €5.60 Billion | €2.11 Billion | €976.61 Million | ▲ +3.5 pp |
| 2016 | 16.8% | €902.01 Million | €5.36 Billion | €1.65 Billion | €752.35 Million | — |